All Biologics Content

Bringing you the latest research in Proteins and Antibodies, Peptides, and Oligonucleotides through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Industry Spotlight
How worrying is the new ‘Langya’ virus spreading in China?
Edited by Tia Byer |
12 August 2022
Vaccines
Industry Spotlight
Statistics show that the number of people infected with the monkeypox virus is starting to slow down.
Edited by Tia Byer |
10 August 2022
Vaccines
Industry Spotlight
The European Commission (EC) has approved Bavarian Nordic’s Imvanex vaccine which protects against monkeypox, and diseases caused by the vaccinia virus.
Edited by Tia Byer |
29 July 2022
Vaccines
Industry Spotlight
Oxford Global’s next round of Biologics Discussion Groups announced.
Edited by Tia Byer |
27 July 2022
Vaccines
Industry Spotlight
Exciting updates revealed about upcoming Vaccines Europe: In-Person congress happening 29-30 November 2022.
Edited by Tia Byer |
20 July 2022
Vaccines
Commentary
Nexelis Principal Scientist, Annett Kleinschmidt, explains the company’s efforts in measuring bactericidal antibody response.
Edited by Tom Cohen |
19 July 2022
Vaccines
Industry Spotlight
The US government has more than doubled its supply of Monkeypox vaccines amidst rising fears.
Edited by Tia Byer |
13 July 2022
Vaccines
Written Q&A
We interview Derek O'Hagan, Senior Advisor at GlaxoSmithKline Vaccines to learn more about the future of the vaccine.
Edited by Tia Byer |
30 June 2022
Vaccines
Industry Spotlight
The poliovirus is on the rise for the first time in nearly 40 years.
Edited by Tia Byer |
29 June 2022
Vaccines
Industry Spotlight
Discover key event highlights from Oxford Global's upcoming Vaccines Congress 2022.
Edited by Tia Byer |
24 June 2022
Vaccines

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login